Liabilities / Assets
27th percentile
Higher debt load relative to assets than 27% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.01x
Liabilities / Revenue
18th percentile
Higher debt load relative to revenue than 18% of similar nonprofits.
Net Margin
79th percentile
Higher net margin than 79% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
100th percentile
Faster asset growth than 100% of similar nonprofits.
Revenue Growth
100th percentile
Faster revenue growth than 100% of similar nonprofits.
Balance Sheet
Assets
Up$267,529
Up $258,471 (+2854%) from 2018
Net Assets
Up$264,994
Up $255,936 (+2826%) from 2018
Liabilities
$2,535
No earlier filing loaded for comparison.
Revenue And Expenses
Revenue
Up$1,176,314
Up $1,163,489 (+9072%) from 2018
Expenses
Up$920,378
Up $916,611 (+24333%) from 2018
Net Income
Up$255,936
Up $246,878 (+2726%) from 2018
Historical Trend
Filing Detail Status
This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2019 to Dec 31, 2019
Mission and Program Overview
Mission
The Aveni Foundation is committed to expediting development of gene-targeted therapies for metastatic cancers and other unmet medical needs.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2019 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $267,529
- Liabilities
- $2,535
- Net assets
- $264,994
- Revenue
- $1,176,314
- Expenses
- $920,378
- Net income
- $255,936